{"id":95423,"date":"2026-05-22T17:04:41","date_gmt":"2026-05-22T11:34:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=95423"},"modified":"2026-05-22T17:04:42","modified_gmt":"2026-05-22T11:34:42","slug":"medico-remedies-analyst-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/","title":{"rendered":"Medico Remedies Analyst Review May 2026"},"content":{"rendered":"<p>This <strong><a href=\"https:\/\/univest.in\/user\/stocks\/medico\/medico-remedies-ltd-share-price-today\">Medico Remedies<\/a> analyst review<\/strong> for May 2026 covers the key data investors need for MEDICOREME at its current price of Rs 145. Medico Remedies (NSE: MEDICOREME) is a pharmaceutical company with a market capitalisation of approximately Rs 250 crore, manufacturing generic formulations for domestic and export markets. The analyst consensus target of Rs 188 implies meaningful upside, and this <strong>Medico Remedies analyst review<\/strong> examines technical levels, business performance, valuation, and key risks for MEDICOREME through FY27.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Medico_Remedies_Company_Snapshot_May_2026\" title=\"Medico Remedies Company Snapshot May 2026\">Medico Remedies Company Snapshot May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Analyst_Insight_in_This_Medico_Remedies_Analyst_Review\" title=\"Analyst Insight in This Medico Remedies Analyst Review\">Analyst Insight in This Medico Remedies Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Technical_Analysis_in_This_Medico_Remedies_Analyst_Review\" title=\"Technical Analysis in This Medico Remedies Analyst Review\">Technical Analysis in This Medico Remedies Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Key_Support_and_Resistance_Levels\" title=\"Key Support and Resistance Levels\">Key Support and Resistance Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Business_Segment_Analysis\" title=\"Business Segment Analysis\">Business Segment Analysis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Generic_Formulations_Tablets_Capsules_Liquids\" title=\"Generic Formulations (Tablets, Capsules, Liquids)\">Generic Formulations (Tablets, Capsules, Liquids)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Domestic_Branded_Generic_Sales\" title=\"Domestic Branded Generic Sales\">Domestic Branded Generic Sales<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Export_of_Generic_Medicines\" title=\"Export of Generic Medicines\">Export of Generic Medicines<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Valuation_in_This_Medico_Remedies_Analyst_Review\" title=\"Valuation in This Medico Remedies Analyst Review\">Valuation in This Medico Remedies Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Trade_Outlook_for_Medico_Remedies\" title=\"Trade Outlook for Medico Remedies\">Trade Outlook for Medico Remedies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Key_Risks_for_Medico_Remedies_in_FY27\" title=\"Key Risks for Medico Remedies in FY27\">Key Risks for Medico Remedies in FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Conclusion_Medico_Remedies_Analyst_Review_Verdict_for_2026\" title=\"Conclusion: Medico Remedies Analyst Review Verdict for 2026\">Conclusion: Medico Remedies Analyst Review Verdict for 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Frequently_Asked_Questions_Medico_Remedies_Analyst_Review_2026\" title=\"Frequently Asked Questions: Medico Remedies Analyst Review 2026\">Frequently Asked Questions: Medico Remedies Analyst Review 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#What_is_the_analyst_target_for_Medico_Remedies_in_2026\" title=\"What is the analyst target for Medico Remedies in 2026?\">What is the analyst target for Medico Remedies in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Is_Medico_Remedies_a_good_investment_at_Rs_145\" title=\"Is Medico Remedies a good investment at Rs 145?\">Is Medico Remedies a good investment at Rs 145?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#What_is_Medico_Remediess_52-week_high_and_low\" title=\"What is Medico Remedies&#8217;s 52-week high and low?\">What is Medico Remedies&#8217;s 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#What_are_the_key_risks_for_Medico_Remedies\" title=\"What are the key risks for Medico Remedies?\">What are the key risks for Medico Remedies?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/medico-remedies-analyst-review-2026\/#Where_can_I_track_live_data_for_Medico_Remedies\" title=\"Where can I track live data for Medico Remedies?\">Where can I track live data for Medico Remedies?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Medico_Remedies_Company_Snapshot_May_2026\"><\/span><strong>Medico Remedies Company Snapshot May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medico Remedies produces tablets, capsules, and liquid formulations across cardiovascular, anti-infective, and gastrointestinal therapy areas for domestic hospital and retail distribution. The table below summarises the key data referenced in this <strong>Medico Remedies analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>MEDICOREME<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceuticals &#8211; Generic Formulations<\/td>\n<\/tr>\n<tr>\n<td>CMP (May 2026)<\/td>\n<td>Rs 145<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 238<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 108<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 250 Crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>18x<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus Target<\/td>\n<td>Rs 188<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 235<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 128<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Insight_in_This_Medico_Remedies_Analyst_Review\"><\/span><strong>Analyst Insight in This Medico Remedies Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Associate Director <strong>Kunal Singla<\/strong> suggests watching Medico Remedies closely in May 2026. At Rs 145, Kunal Singla flags Pharmaceuticals &#8211; Generic Formulations sector dynamics as the primary driver for MEDICOREME&#8217;s near-term price action. He notes support in the Rs 110.16 to Rs 137.75 zone and flags a sustained close above Rs 153.70 as a positive signal. Kunal Singla&#8217;s perspective adds professional analysis to this <strong>Medico Remedies analyst review<\/strong> and is not a buy recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_in_This_Medico_Remedies_Analyst_Review\"><\/span><strong>Technical Analysis in This Medico Remedies Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 145, MEDICOREME is trading within its 52-week band of Rs 108 to Rs 238. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.<\/p>\n<p>Near-term support is identified in the Rs 110.16 to Rs 137.75 band while resistance is seen in the Rs 153.70 to Rs 166.50 zone. A sustained move above Rs 153.70 could open the path toward the analyst consensus target of Rs 188 as identified in this <strong>Medico Remedies analyst review<\/strong>.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Support_and_Resistance_Levels\"><\/span><strong>Key Support and Resistance Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Support Zone:<\/strong> Rs 110.16 to Rs 137.75 &#8211; investors tracking this <strong>Medico Remedies analyst review<\/strong> should watch for stabilisation or a bounce in this range as a potential accumulation signal for MEDICOREME.<\/li>\n<li><strong>Resistance Zone:<\/strong> Rs 153.70 to Rs 166.50 &#8211; a sustained close above Rs 153.70 would be a positive breakout signal worth flagging in this <strong>Medico Remedies analyst review<\/strong>.<\/li>\n<li><strong>Medium-Term Target:<\/strong> The analyst consensus of Rs 188 represents the base-case upside scenario in this <strong>Medico Remedies analyst review<\/strong>.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Business_Segment_Analysis\"><\/span><strong>Business Segment Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Generic_Formulations_Tablets_Capsules_Liquids\"><\/span><strong>Generic Formulations (Tablets, Capsules, Liquids)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This is the primary revenue and margin driver for Medico Remedies, directly supporting the earnings trajectory toward the consensus target of Rs 188.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Domestic_Branded_Generic_Sales\"><\/span><strong>Domestic Branded Generic Sales<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This segment adds scale and diversification to Medico Remedies&#8217;s business model and is a meaningful EPS contributor through FY27 and FY28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Export_of_Generic_Medicines\"><\/span><strong>Export of Generic Medicines<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This represents the medium-term growth frontier for Medico Remedies and a key re-rating catalyst for the stock over the next 12 to 24 months.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_in_This_Medico_Remedies_Analyst_Review\"><\/span><strong>Valuation in This Medico Remedies Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 145, Medico Remedies trades at a trailing P\/E of 18x. This <strong>Medico Remedies analyst review<\/strong> presents three scenarios: a bull case of Rs 235 on strong earnings delivery, a base case of Rs 188 at analyst consensus, and a bear case of Rs 128 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this <strong>Medico Remedies analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target Price<\/th>\n<th>Key Condition<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 235<\/td>\n<td>Strong earnings delivery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Consensus)<\/td>\n<td>Rs 188<\/td>\n<td>Moderate growth, analyst consensus estimate<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 128<\/td>\n<td>Earnings miss or macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Trade_Outlook_for_Medico_Remedies\"><\/span><strong>Trade Outlook for Medico Remedies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Based on the technical and fundamental analysis in this <strong>Medico Remedies analyst review<\/strong>, investors might watch MEDICOREME near the support zone of Rs 110.16 to Rs 137.75 for potential opportunities. A flag above Rs 153.70 could suggest improving momentum toward Rs 188. This article uses watch-and-flag language only and does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Medico_Remedies_in_FY27\"><\/span><strong>Key Risks for Medico Remedies in FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A well-rounded <strong>Medico Remedies analyst review<\/strong> must assess downside risks. Key risks for Medico Remedies include a macro slowdown affecting Pharmaceuticals &#8211; Generic Formulations sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in MEDICOREME.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Medico_Remedies_Analyst_Review_Verdict_for_2026\"><\/span><strong>Conclusion: Medico Remedies Analyst Review Verdict for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Medico Remedies analyst review<\/strong> concludes that at Rs 145, MEDICOREME offers a defined risk-reward with a consensus target of Rs 188. The 52-week range of Rs 108 to Rs 238 provides context on the current entry point. Use this <strong>Medico Remedies analyst review<\/strong> as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on MEDICOREME.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_Medico_Remedies_Analyst_Review_2026\"><\/span><strong>Frequently Asked Questions: Medico Remedies Analyst Review 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_analyst_target_for_Medico_Remedies_in_2026\"><\/span><strong>What is the analyst target for Medico Remedies in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The analyst consensus target is Rs 188, with a bull case of Rs 235 and a bear case of Rs 128. This <strong>Medico Remedies analyst review<\/strong> recommends monitoring Q1 FY27 earnings for confirmation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Medico_Remedies_a_good_investment_at_Rs_145\"><\/span><strong>Is Medico Remedies a good investment at Rs 145?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 145 with a P\/E of 18x and a consensus target of Rs 188, this <strong>Medico Remedies analyst review<\/strong> is constructive for medium to long-term investors in the Pharmaceuticals &#8211; Generic Formulations sector. Always consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Medico_Remediess_52-week_high_and_low\"><\/span><strong>What is Medico Remedies&#8217;s 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 52-week high is Rs 238 and the 52-week low is Rs 108. At Rs 145, MEDICOREME is positioned within this range as noted in this <strong>Medico Remedies analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Medico_Remedies\"><\/span><strong>What are the key risks for Medico Remedies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Pharmaceuticals &#8211; Generic Formulations sector as assessed in this <strong>Medico Remedies analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_live_data_for_Medico_Remedies\"><\/span><strong>Where can I track live data for Medico Remedies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track Medico Remedies&#8217;s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this <strong>Medico Remedies analyst review<\/strong>.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medico Remedies analyst review 2026: CMP Rs 145, MCap Rs 250 Cr, PE 18x. Pharmaceuticals &#8211; Generic Formulations outlook. May 2026.<\/p>\n","protected":false},"author":28,"featured_media":95506,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-95423","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779449685:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Medico Remedies Analyst Review 2026: Key Levels and Outlook"],"rank_math_description":["Medico Remedies analyst review 2026: CMP Rs 145, MCap Rs 250 Cr, PE 18x. Pharmaceuticals - Generic Formulations outlook. May 2026."],"rank_math_focus_keyword":["Medico Remedies Analyst Review"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["95506"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["13100"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/22170429\/Medico-Remedies-Analyst-Review.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/95423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=95423"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/95423\/revisions"}],"predecessor-version":[{"id":95508,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/95423\/revisions\/95508"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/95506"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=95423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=95423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=95423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}